VMD is a rare disease with autosomal dominant inheritance. It can occur in any age group, but when it is detected in younger patients between 3 and 15 years of age, it is considered to be a Best vitelliform macular dystrophy, and in patients ages between 30 and 50 years, it is considered to be adult-onset VMD with differences in the clinical appearance. It was recently discovered, however, that both are due to abnormalities of the Best1 gene with different phenotypes and its primary cause is abnormalities in bestrophin function [8, 9].
Typical fundus findings in VMD are egg yolk-like, round or oval, lesions found in the bilateral macula. The exact location of the deposits in the retina is unclear, but based on spectral domain-OCT [17], they are located beneath the sensory retina, causing changes in the photoreceptor inner segment/outer segments. The cause of the egg yolk-like yellowish deposits is unknown, but may be due to unphagocytosed outer segments that accumulate because of the lack of apposition of the outer membrane segments to the RPE. The persistence of the material in the subretinal space increases the likelihood of the formation of lipofuscin precursors, which are autofluorescent and susceptible to oxidative damage [12]. In histologic examination, these lipofuscins appear as egg yolk-like lesions [18]. In the advanced disease state, lipofuscins normally get reabsorbed or disappear, and cause atrophy in the RPE. The findings of fluorescein angiography vary based on the yellowish lesions, usually hypofluorescence in the central lesions and a window defect can be seen, and in FAF, the fluorescence of the lesions is irregularly increased or decreased [19].
In EOG, a decrease in the Arden ratio is a distinctive feature of VMD [14], due to a defect in Ca2+ activated Cl- channels of the RPE basolateral membrane that expresses bestrophin. Until recently, EOG has been the most accurate test for determining the cause of the disease as well as genetic examination.
At a young age, bilateral neurosensory retinal detachment can be caused by infections, inflammation, collagen-vascular disease, tumor, age-related macular degeneration, polypoidal choroidal vasculopathy, and CSC. In the presented cases, there were no symptoms of infection or inflammation, and both systemic disease and tumor were also excluded. Age-related macular degeneration usually occurs at an advanced age, and polypoidal choroidal vasculopathy can occur at a young age, but polypoidal dilation was not observed on indocyanine green angiography so it was excluded. Therefore, chronic CSC was suspected based on the examinations and clinical features in these cases.
Based on the clinical features, the patients were diagnosed with chronic CSC and received photodynamic treatment for months. Case 1 received intravitreal bevacizumab injection and laser photocoagulation therapy to coagulate the leaking points but serous retinal detachment persisted for 2 years. Also, there was no change in the autofluorescence for several years compared to the baseline.
The common clinical features of the two cases led us to review the patient records since the first visit. Although both cases had a prolonged disease state, there was no decrease in visual acuity, atrophic lesions in the macula region were observed, fluorescein angiography showed hypofluorescence in the macula, hyperfluorescence in the surrounding areas, and a window defect in the surrounding region due to atrophy in the RPE layer. Especially in FAF, both cases showed increased autofluorescence in the border of serous retinal detachment, and yellowish lesions were located below and around the serous retinal detachment in the fundus photograph. Spectral domain-OCT was used to scan the area and showed hyper-reflective lesions between the RPE layer and the photoreceptor IS/OS junction. We suspected VMD in these two cases, because when VMD progresses, the yellowish egg yolk-like lesions in VMD get absorbed spontaneously or form fluid, which can make it difficult to find definite lesions, and we observed atrophic lesions of the macula and continuous subretinal fluid. The source of the subretinal fluid appears to be related to the underlying defect in VMD2, which involves bestrophin, a Ca2+ -sensitive Cl– channel protein found in the basolateral portion of the RPE cells [12]. The EOG revealed a decrease in the Arden ratio in both patients. Additionally, genetic examination revealed the mutation in VMD2 gene, which led to a definite diagnosis. The reasons why visual acuity was maintained even after long-lasting VMD as follows were that the patient was comparably young, and photoreceptor inner segment/outer segment junction was not disrupted, which was confirmed by SD-OCT, even with RPE atrophy after long standing serous retinal detachment (Figure 8).
In the case of CSC, as the disease state progresses hyperautofluorescence or hypoautofluorescence can be seen in FAF, but it is uncommon to find an overall decrease in autofluorescence in the center and an increase in autofluorescence at the border of the serous retinal detachment in CSC. Normally, egg yolk-like lesions in VMD are lipofuscins, which can lead to an increase in autofluorescence in the lesion areas. In these cases, the autofluorescence decreased due to the absorption of lesions in the central area and continuous serous retinal detachment, and autofluorescence increased due to the existence of deposits at the bottom border of the serous retinal detachment and around the area of the serous detachment. Especially in the second case, fundus photography and slit lamp examination revealed no yellowish deposits, but FAF showed hyperautofluorescence in the border of serous retinal detachment, so it was very helpful for making a diagnosis.